Women treated for cervical precancerous lesions known as CIN3 have a relatively low risk of developing invasive Cervical cancer afterward. Studies suggest that the risk of progression to cancer is generally less than 1% within 20 years following appropriate treatment. However, regular follow-up and screenings are essential for early detection and management of any potential recurrence or new lesions.